Literature DB >> 300388

Analysis of the major histocompatibility complex in Syrian hamsters. III. Cellular and humoral immunity to alloantigens.

W R Duncan.   

Abstract

Among the genetic loci incorporated into the major histocompatibility complex in every species studied to date have been prominent genes encoding for strong histocompatibility determinants that elicit detectable alloantibody responses and which are the chief antigenic targets of cell-mediated cytotoxicity reactions. The K and D regions of the H-2 complex in the mouse and the A, B, and C regions of the HLA complex in man are representative examples. Syrian hamsters, as described in this report, do not make alloantibodies to antigens of this type and only very poorly do they carry out in vitro cell-mediated cytotoxicity to target cells putatively bearing these antigens. Since hamsters are quite capable of discriminating analogous antigenic differences in xenogeneic species, and xenogeneic sources cannot distinguish immunologically between the antigens encoded by the two hamster major histocompatibility alleles. Hm-1a and Hm-1b, we conclude that the hamster strains we work with are serologically indistinguishable by the methods used here. However, they obviously differ for determinants which elicit T cell-mediated responses, as evidenced by their ability to express acute skin graft rejection, mixed lymphocyte reactivity, graft-vs-host reactions, and cell-mediated cytotoxicity reactions. Such alloreactivity may reflect a mutation at an SD locus, affecting antigenic sites recognized only by T cells, or that the available hamster strains are SD identical, but differ at loci similar to the I region loci in mice. Alternatively, we cannot exclude the possibility that Syrian hamsters somehow fail to express properly the genes coding for SD determinants.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300388

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  In vivo studies of spleen lymphoid cells implicated in antitumor immunity in hamsters.

Authors:  H Haddada; C de Vaux Saint Cyr; A Duthu
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  The biochemical characterization of Syrian hamster cell-surface alloantigens. II. Immunochemical relationships between cell-surface alloantigens and class II MHC homologues.

Authors:  J T Phillips; W R Duncan; J W Streilein
Journal:  Immunogenetics       Date:  1981-03-01       Impact factor: 2.846

3.  Genetic analyses of alloreactions between recently wild and classical inbred strains of Syrian hamsters: evidence in favor of a major histocompatibility complex.

Authors:  W R Duncan; J W Streilein
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  The Biochemical characterization of syrian hamster cell-surface alloantigen : I. Analysis of allogeneic differences between recently wild and highly inbred hamsters.

Authors:  J T Phillips; J W Streilein; W R Duncan
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

5.  Transplantation of insulinoma into the diabetic Syrian hamster.

Authors:  D Reintgen; J Feldman; C Vervaert; H F Seigler
Journal:  Ann Surg       Date:  1980-01       Impact factor: 12.969

6.  Hamster T cells participate in MHC alloimmune reactions but do not effect virus-induced cytotoxic activity.

Authors:  M J Nelles; J W Streilein
Journal:  Immunogenetics       Date:  1980-07       Impact factor: 2.846

7.  Syrian hamster DNA shows limited polymorphism at class I-like loci.

Authors:  K L McGuire; W R Duncan; P W Tucker
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

8.  Immune response to acute virus infection in the Syrian hamster. I. Studies on genetic restriction of cell-mediated cytotoxicity.

Authors:  M J Nelles; J W Streilein
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

9.  Syrian hamsters express two monomorphic class I major histocompatibility complex molecules.

Authors:  A G Darden; J W Streilein
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.